|
Real-time Estimate
Cboe BZX
18:31:48 22/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 448.44 USD | +2.30% |
|
+3.01% | +36.59% |
| 10-21 | Barclays Adjusts Price Target on Amgen to $400 From $380 | MT |
| 10-21 | Positive Results for an AstraZeneca and Amgen Product |  |
ETFs positioned on Amgen Inc.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +17.36% | - | 35,761 M€ | |
| +10.02% | - | 27,154 M€ | |
| +5.24% | - | 49 M€ | |
| +10.99% | - | 66 M€ | |
| +9.80% | - | 67 M€ | |
| +10.68% | - | 67 M€ | |
| +10.00% | - | 75 M€ | |
| +12.21% | - | 122 M€ | |
| +3.66% | - | 165 M€ | |
| +5.34% | - | 33 M€ | |
| +18.01% | - | 669 M€ | |
| +10.23% | - | 1,251 M€ | |
| +17.44% | - | 1,646 M€ | |
| +12.23% | - | 1,674 M€ | |
| +13.27% | - | 2,210 M€ | |
| +16.32% | - | 2,303 M€ | |
| +10.86% | - | 12,921 M€ | |
| +29.90% | 17.04% | 429 M€ | |
| +25.01% | 8.97% | 1,079 M€ | |
| +24.83% | 8.97% | 78 M€ | |
| +22.84% | 8.81% | 9,953 M€ | |
| +22.55% | 7.76% | 81 M€ | |
| +18.10% | 7.16% | 503 M€ | |
| -1.47% | 6.85% | 5 M€ | |
| +19.40% | 5.86% | 379 M€ | |
| +13.28% | 5.41% | 7 M€ | |
| 0.00% | 4.96% | 5 M€ |
Employees
31,500
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- AMGN Stock
- ETFs Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
